@article{ref1,
title="An open-label study to evaluate the transition of patients with chronic plaque psoriasis from cyclosporine to alefacept",
journal="Journal of drugs in dermatology",
year="2007",
author="Magliocco, Melissa A. and Lozano, Ann Marie and Van Saders, Claudia and Schuler, Kristine W. and Gottlieb, Alice B.",
volume="6",
number="4",
pages="424-427",
abstract="Eleven patients with well-controlled psoriasis on cyclosporine (Physician's Global Assessment [PGA] of &quot;mild&quot; or better) participated in an open-label study that evaluated a strategy for transition to alefacept. Using this transition strategy, 7 of 11 patients (64%) maintained PGA scores. Quality of life improved or was maintained in all patients. Adverse events and reductions in CD4+ T cell counts were consistent with those seen during alefacept monotherapy.<p /><p>Language: en</p>",
language="en",
issn="1545-9616",
doi="",
url="http://dx.doi.org/"
}